FMED

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-5.09%	Total Holdings	70	Perf Week	-1.74%
Sponsor	Fidelity	ETF Type		Tags	equity	Return% 3Y	-	AUM	54.73M	Perf Month	2.53%
Fund Family		Bond Type		Tags	technology	Return% 5Y	-	NAV/sh		Perf Quarter	2.78%
Index	-	Average Maturity		Tags	medical	Return% 10Y		52W High	26.79 -8.23%	Perf Half Y	4.19%
Index Weighting		Commodity Type		Tags	disruptive	Return% SI		52W Low	20.69 18.82%	Perf YTD	-0.31%
Active/Passive		Quant Type		Tags	innovation	Flows% 1M	0.00%	Volatility	0.90% 0.95%	Perf Year	-5.09%
Dividend TTM	0.11 (0.46%)	ESG Type		Tags	-	Flows% 3M	0.00%	ATR (14)	0.28	Perf 3Y	-
Dividend Ex-Date	Dec 20, 2024	Dividend Type		Sector/Theme		Flows% YTD	4.51%	RSI (14)	52.67	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.02	Perf 10Y	-
Expense	0.50%	Growth/Value		SMA20	-0.01%	Flows% 3Y		Rel Volume	0.40	Prev Close	24.89
Inverse/Leveraged		Market Cap		SMA50	2.09%	Flows% 5Y		Avg Volume	4.67K	Price	24.58
IPO	Jun 12, 2023	Option/Short	No / Yes	SMA200	0.72%	Trades		Volume	1,865	Change	-1.21%

May-05-25 12:12PM

First Look At FMED: Poor Performance Merits A Strong Sell Rating

(Seeking Alpha)

Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

Fidelity Disruptive Medicine ETF

Upgrade your FINVIZ experience